Drug Profile
Budesonide oral suspension - Takeda
Alternative Names: Eohilia; Oral viscous budesonide; SHP-621; TAK-721Latest Information Update: 15 Feb 2024
Price :
$50
*
At a glance
- Originator Verus Pharmaceuticals
- Developer Takeda
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Eosinophilic oesophagitis